Get the Stockscreener App
270.87
0.74%
1.98
After Hours:
270.87
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $270.87, with a volume of 1.06M.
It is up +0.74% in the last 24 hours and up +4.94% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$268.89
Open:
$267.09
24h Volume:
1.06M
Relative Volume:
1.28
Market Cap:
$22.46B
Revenue:
$13.48B
Net Income/Loss:
$764.50M
P/E Ratio:
29.87
EPS:
9.0688
Net Cash Flow:
$1.26B
1W Performance:
+7.57%
1M Performance:
+4.94%
6M Performance:
+10.12%
1Y Performance:
+13.44%
1-Day Range:
$265.86
$271.61
1-Week Range:
$248.20
$271.61
52-Week Range:
$209.38
$293.72
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
270.87 | 22.29B | 13.48B | 764.50M | 1.26B | 9.0688 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Navera Investment Management Ltd. Sells 11,643 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Community Health Completes Asset Sale to LabCorp - MSN
Labcorp Holdings' (NYSE:LH) Dividend Will Be $0.72 - simplywall.st
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Yahoo Finance
Ideas Watch: Can Labcorp Holdings Inc disrupt its industryPrice Action & Daily Growth Stock Tips - baoquankhu1.vn
Labcorp to Settle Patient Privacy Dispute Over Online Trackers - Bloomberg Law News
Manning & Napier Advisors LLC Decreases Stock Position in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp’s quarterly earnings preview: What you need to know - MSN
Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion? - Yahoo Finance
Labcorp Holdings Board Declares Quarterly Cash Dividend - The Globe and Mail
Labcorp Schedules Q4 2025 Earnings Release and Call - TipRanks
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 - Finviz
Labcorp Holdings Inc to Announce Q4 2025 Financial Results - TradingView — Track All Markets
Labcorp Declares Quarterly Dividend - Sahm
Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Nigeria
Labcorp Holdings Inc. to Issue Quarterly Dividend of $0.72 (NYSE:LH) - MarketBeat
Press Release: Labcorp Declares Quarterly Dividend - 富途牛牛
Baird Adjusts Labcorp Price Target to $313 From $307, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. Declares Quarterly Dividend, Payable on March 12, 2026 - marketscreener.com
Labcorp Holdings Maintains Quarterly Dividend of $0.72 a Share, Payable March 12 to Shareholders of Record as of Feb. 27 - marketscreener.com
Labcorp declares quarterly dividend of $0.72 per share - Investing.com
Labcorp Holdings Inc. (LH) Declares Cash Dividend for Shareholders - GuruFocus
Labcorp’s Expanded Plasma Detect MRD Portfolio Could Be A Game Changer For Labcorp Holdings (LH) - Sahm
Labcorp expands cancer recurrence testing for breast, lung, colon cancers By Investing.com - Investing.com Canada
Labcorp expands cancer recurrence testing for breast, lung, colon cancers - Investing.com
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk - Finviz
Labcorp Holdings Inc. $LH Shares Sold by Nordea Investment Management AB - MarketBeat
Blood test from Labcorp spots breast, lung and colon cancer earlier - Stock Titan
Assessing Labcorp Holdings (LH) Valuation After A Recent 10.5% Three Month Share Price Decline - Yahoo Finance
Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options - GlobeNewswire Inc.
SG Americas Securities LLC Acquires 17,723 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue? - MSN
Will Labcorp Holdings Inc. stock outperform tech sector in 2025Market Risk Summary & Community Supported Trade Ideas - Улправда
Labcorp Holdings Inc. $LH Shares Sold by Cerity Partners LLC - MarketBeat
Labcorp (NYSE:LH) Downgraded by Wall Street Zen to "Hold" - MarketBeat
Labcorp’s Quarterly Earnings Preview: What You Need to Know - Barchart.com
NAMSA acquires Labcorp’s medical device testing assets - Yahoo Finance
Is Labcorp Holdings Inc. stock worth holding before Fed meetingMarket Risk Summary & Growth Focused Entry Reports - ulpravda.ru
Is Labcorp Holdings Inc. stock supported by strong cash flowsBreakout Watch & Weekly High Return Forecasts - ulpravda.ru
Labcorp Holdings Stock: Analyst Estimates & Ratings - MSN
Can Labcorp Holdings Inc. stock beat market expectations this quarterQuarterly Investment Review & AI Powered Buy and Sell Recommendations - Улправда
Is Labcorp Holdings Inc. stock a top pick in earnings seasonWeekly Gains Report & Stepwise Trade Execution Plans - Улправда
Is Labcorp Holdings Inc. (N6B) stock safe for risk averse investorsJuly 2025 Selloffs & Daily Profit Maximizing Tips - Улправда
Will Labcorp Holdings Inc. stock remain a Wall Street favoriteMarket Performance Recap & Long Hold Capital Preservation Plans - Улправда
Will Labcorp Holdings Inc. stock benefit from upcoming earnings reportsEarnings Summary Report & Weekly Sector Rotation Insights - Улправда
Labcorp falls as 2025 revenue guidance midpoint lowered - MSN
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp - Finviz
Visby engages Quest and Labcorp to broaden consumer access to first at-home, FDA-authorized PCR test for STIs - marketscreener.com
New 30-minute at-home test helps women detect STIs privately - Stock Titan
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp – Company AnnouncementFT.com - Financial Times
Birch Hill Investment Advisors LLC Cuts Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):